Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v13-EN | Version v1-EN | |
|---|---|---|
| Language | English | English |
| Date Updated | 2019-03-22 | 2018-06-15 |
| Drug Identification Number | 02347393 | 02347393 |
| Brand name | MENVEO | MENVEO |
| Common or Proper name | Meningococcal (Groups A, C, W-135 and Y) Oligosaccharide CRM-197 Conjugate Vaccine | Meningococcal (Groups A, C, W-135 and Y) Oligosaccharide CRM-197 Conjugate Vaccine |
| Company Name | GLAXOSMITHKLINE INC | GLAXOSMITHKLINE INC |
| Ingredients | MENINGOCOCCAL GROUP C OLIGOSACCHARIDE CORYNEBACTERIUM DIPHTHERIAE CRM-197 PROTEIN MENINGOCOCCAL GROUP A OLIGOSACCHARIDE MENINGOCOCCAL GROUP Y OLIGOSACCHARIDE MENINGOCOCCAL GROUP W-135 OLIGOSACCHARIDE | MENINGOCOCCAL GROUP C OLIGOSACCHARIDE CORYNEBACTERIUM DIPHTHERIAE CRM-197 PROTEIN MENINGOCOCCAL GROUP A OLIGOSACCHARIDE MENINGOCOCCAL GROUP Y OLIGOSACCHARIDE MENINGOCOCCAL GROUP W-135 OLIGOSACCHARIDE |
| Strength(s) | 5MCG 47MCG 10MCG 5MCG 5MCG | 5MCG 47MCG 10MCG 5MCG 5MCG |
| Dosage form(s) | SOLUTION POWDER FOR SOLUTION | SOLUTION POWDER FOR SOLUTION |
| Route of administration | INTRAMUSCULAR | INTRAMUSCULAR |
| Packaging size | 1's | 1's |
| ATC code | J07AH | J07AH |
| ATC description | BACTERIAL VACCINES | BACTERIAL VACCINES |
| Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
| Anticipated start date | ||
| Actual start date | 2018-06-14 | 2018-06-14 |
| Estimated end date | 2019-05-07 | 2018-12-31 |
| Actual end date | ||
| Shortage status | Actual shortage | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | Supply unavailable in the private market. Supply available for public programs. | No re-supply temporarily and remaining inventory under allocation. Supply disruptions may be seen in the private market. Menveo is available in packages of 5. |
| Health Canada comments |